Wnt signaling pathway and lung disease

Translational Research

Volumn 151, Issue 4, 2008, Pages 175-180

  Van Scoyk, Michelle ^a   Randall, Jessica ^a   Sergew, Amen ^a   Williams, Lisa M ^a   Tennis, Meredith ^a   Winn, Robert A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ICG 001; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN INHIBITOR; SMALL INTERFERING RNA; SULINDAC; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULTHOOD; APOPTOSIS; ASTHMA; BREAST CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; DRUG TARGETING; HUMAN; INTERSTITIAL LUNG DISEASE; LEUKEMIA; LUNG CANCER; LUNG DEVELOPMENT; LUNG DISEASE; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCREENING TEST; SIGNAL TRANSDUCTION; STEM CELL; THYROID CANCER;

EID: 40849083445     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.12.011     Document Type: Review

References (59)

1. Widelitz R. Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23 (2005) 111-116
2. Oishi I., Suzuki H., Onishi N., et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8 (2003) 645-654
3. Chen A.E., Ginty D.D., and Fan C.M. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433 (2005) 317-322
4. Schulte G., and Bryja V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci 28 (2007) 518-525
5. Quaiser T., Anton R., and Kuhl M. Kinases and G proteins join the Wnt receptor complex. Bioessays 28 (2006) 339-343
6. Kikuchi A., Yamamoto H., and Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 19 (2007) 659-671
7. Pongracz J.E., and Stockley R.A. Wnt signalling in lung development and diseases. Respir Res 7 (2006) 15
8. He X., and Axelrod J.D. A WNTer wonderland in Snowbird. Development 133 (2006) 2597-2603
9. Kawano Y., and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116 (2003) 2627-2634
10. Lin K., Wang S., Julius M.A., Kitajewski J., Moos Jr. M., and Luyten F.P. The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci USA 94 (1997) 11196-11200
11. Uren A., Reichsman F., Anest V., et al. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275 (2000) 4374-4382
12. Brott B.K., and Sokol S.Y. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22 (2002) 6100-6110
13. Qin X., Zhang H., Zhou X., Wang C., Zhang X., and Ye L. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res 150 (2007) 281-294
14. He X., Semenov M., Tamai K., and Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131 (2004) 1663-1677
15. Mao B., and Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302 (2003) 179-183
16. Semenov M.V., Tamai K., Brott B.K., Kuhl M., Sokol S., and He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11 (2001) 951-961
17. Shannon J.M., and Hyatt B.A. Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 66 (2004) 625-645
18. Minoo P., Hamdan H., Bu D., Warburton D., Stepanik P., and deLemos R. TTF-1 regulates lung epithelial morphogenesis. Dev Biol 172 (1995) 694-698
19. Tebar M., Destree O., de Vree W.J., and Ten Have-Opbroek A.A. Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. Mech Dev 109 (2001) 437-440
20. Shu W., Jiang Y.Q., Lu M.M., and Morrisey E.E. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 129 (2002) 4831-4842
21. Li C., Xiao J., Hormi K., Borok Z., and Minoo P. Wnt5a participates in distal lung morphogenesis. Dev Biol 248 (2002) 68-81
22. Mucenski M.L., Nation J.M., Thitoff A.R., et al. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol 289 (2005) L971-L979
23. Karner C., Wharton K.A., and Carroll T.J. Apical-basal polarity, Wnt signaling and vertebrate organogenesis. Semin Cell Dev Biol 17 (2006) 214-222
24. Winn R.A., Marek L., Han S.Y., et al. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J Biol Chem 280 (2005) 19625-19634
25. Pizzuti A., Amati F., Calabrese G., et al. cDNA characterization and chromosomal mapping of two human homologues of the Drosophila dishevelled polarity gene. Hum Mol Genet 5 (1996) 953-958
26. Nozaki I., Tsuji T., Iijima O., et al. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 19 (2001) 117-121
27. Borthwick D.W., Shahbazian M., Krantz Q.T., Dorin J.R., and Randell S.H. Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 24 (2001) 662-670
28. Kotton D.N., and Fine A. Lung stem cells. Cell Tissue Res 331 (2008) 145-156
29. He B., and Jablons D.M. Wnt signaling in stem cells and lung cancer. Ernst Schering Found Symp Proc 5 (2006) 27-58
30. Reguart N., He B., Taron M., You L., Jablons D.M., and Rosell R. The role of Wnt signaling in cancer and stem cells. Future Oncol 1 (2005) 787-797
31. Calvo R., West J., Franklin W., et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci USA 97 (2000) 12776-12781
32. Winn R.A., Van Scoyk M., Hammond M., et al. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor {gamma}. J Biol Chem 281 (2006) 26943-26950
33. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
34. Early D.S., Fontana L., and Davidson N.O. Translational approaches to addressing complex genetic pathways in colorectal cancer. Transl Res 151 (2008) 10-16
35. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
36. Sparks A.B., Morin P.J., Vogelstein B., and Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58 (1998) 1130-1134
37. Ohgaki H., Kros J.M., Okamoto Y., Gaspert A., Huang H., and Kurrer M.O. APC mutations are infrequent but present in human lung cancer. Cancer Lett 207 (2004) 197-203
38. Sunaga N., Kohno T., Kolligs F.T., Fearon E.R., Saito R., and Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30 (2001) 316-321
39. Ueda M., Gemmill R.M., West J., et al. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85 (2001) 64-68
40. He B., You L., Uematsu K., et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6 (2004) 7-14
41. You L., He B., Xu Z., et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23 (2004) 6170-6174
42. Uematsu K., He B., You L., Xu Z., McCormick F., and Jablons D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22 (2003) 7218-7221
43. Mazieres J., He B., You L., et al. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64 (2004) 4717-4720
44. Wissmann C., Wild P.J., Kaiser S., et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201 (2003) 204-212
45. Fukui T., Kondo M., Ito G., et al. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24 (2005) 6323-6327
46. Tang M., Torres-Lanzas J., Lopez-Rios F., Esteller M., and Sanchez-Cespedes M. Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung. Int J Cancer 119 (2006) 2603-2606
47. Dehan E., Ben-Dor A., Liao W., et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 56 (2007) 175-184
48. Morrisey E.E. Wnt signaling and pulmonary fibrosis. Am J Pathol 162 (2003) 1393-1397
49. Chilosi M., Poletti V., Zamo A., et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162 (2003) 1495-1502
50. Syed F., Huang C.C., Li K., et al. Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells. Biomarkers 12 (2007) 414-423
51. Koornstra J.J., Rijcken F.E., Oldenhuis C.N., et al. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev 14 (2005) 1608-1612
52. Boon E.M., Keller J.J., Wormhoudt T.A., et al. Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer 90 (2004) 224-229
53. Lepourcelet M., Chen Y.N., France D.S., et al. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5 (2004) 91-102
54. Emami K.H., Nguyen C., Ma H., et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. [corrected]. Proc Natl Acad Sci USA 101 (2004) 12682-12687
55. He B., Lee A.Y., Dadfarmay S., et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 65 (2005) 743-748
56. You L., Kim J., He B., Xu Z., McCormick F., and Jablons D.M. Wnt-1 signal as a potential cancer therapeutic target. Drug News Perspect 19 (2006) 27-31
57. Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13 (2007) 4042-4045
58. Hu Y., Le Leu R.K., and Young G.P. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice. Int J Cancer 116 (2005) 870-875
59. Sun B.C., Zhao X.L., Zhang S.W., Liu Y.X., Wang L., and Wang X. Sulindac induces apoptosis and protects against colon carcinoma in mice. World J Gastroenterol 11 (2005) 2822-2826